Clinical Research Dermatology FDA Approval Pharma Companies 
XTalks
DECEMBER 20, 2023
And this year Eli Lilly stepped into the obesity drug market with its own GLP-1 weight loss drug Zepbound (tirzepatide), which the US Food and Drug Administration (FDA) approved in November of this year. Check out this article to learn about the biotech companies that went public this year.
pharmaphorum
JULY 8, 2022
Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. It needs to be performed with a benchmark, an FDA-approved device.”. Novel digital endpoints. About the interviewees.
Expert insights. Personalized for you.
59 
Let's personalize your content